Interventional Neurology Market Share Geographical Segmentation, Comprehensive Analysis to 2030

Interventional Neurology Market Insights:

In a recent research report by Market Research Community, the interventional neurology market is expected to surpass USD 3.85 Billion by the year 2030, from USD 2.46 Billion in 2021.

Interventional Neurology is one of the branches of neurology. Catheters and radiography are employed during surgical interventions such as coil embolization, stenting, and others for the treatment of conditions like intracranial atherosclerotic disease and cerebral aneurysms. Interventional neurology utilizes instruments that pass through the blood vessels which help in the diagnosis of diseases and reduced the need for open surgery.

The flow diversion segment is expected to witness substantial growth in 2021. The factors such as increased endothelial regrowth, precise endoluminal reconstruction, and reduced need for doctors’ intervention for the elimination of aneurysms are projected to support the growth of the flow diversion segment during the forecast period.

Asia-Pacific is estimated to contribute the second largest market share in the increased growth of the interventional neurology market in the forecast period. The factors such as the rise in healthcare infrastructure development, the increased prevalence of risk factors such as diabetes, obesity, and hypertension which lead to neurovascular diseases, especially among the geriatric population, and increased numbers of neurovascular incidences are the major contributors to the growth of the interventional neurology market in the region.

The market is projected to grow at a significant pace reaching a CAGR of approximately 5.4%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of the pandemic spread and lockdown restrictions imposed globally.

The study is consolidated into major segments and further into sub-segments, such as by product type (aneurysm coiling devices and cerebral embolization (embolic coils, flow diversion devices, liquid embolic agents), neurothrombectomy devices, cerebral angioplasty and stenting systems, support devices), by disease pathology (arteriovenous malformation and fistulas,  cerebral aneurysms, ischemic strokes, others (cavernous malformations and Moyamoya disease)), by technique (neurothrombectomy procedure, cerebral angiography technique, carotid endarterectomy (CEA), stenting, microsurgical clipping, coiling, flow diversion, and others), by end-use (hospitals & surgical centers, ambulatory care centers, research laboratories & academic institutes), to forecast the interventional neurology market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.                     

Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra Inc., Microport Scientific Corporation, Merit Medical Systems Inc., W.L. Gore & Associates Inc., B. Braun.


Market Research Community

(US) +1-214-272-0393

(UK) +44-20-8133-9198


Comments are closed